| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $5.17B | -10.4% |
| Cost of Revenue | $1.43B | -9.1% |
| Gross Profit | $3.73B | -10.9% |
| R&D Expense | $755.9M | -15.4% |
| SG&A Expense | $427.8M | -25.9% |
| Operating Income | $892.7M | +0.6% |
| Pre-tax Income | $482.1M | -33.9% |
| Income Tax | $46.0M | -82.6% |
| Net Income | $435.9M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.16B | -9.7% |
| Accounts Receivable | $659.7M | +5.3% |
| Current Assets | $2.20B | -3.3% |
| Total Assets | $13.77B | -3.0% |
| Current Liabilities | $2.75B | -1.9% |
| Long-term Debt | $6.38B | -0.2% |
| Stockholders' Equity | $3.93B | -6.4% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $830.6M | -14.2% |
| Investing Cash Flow | -$153.5M | -107.5% |
| Financing Cash Flow | -$834.7M | +71.8% |
| -6.3% |
| EPS (Basic) | $1.66 | -2.9% |
| EPS (Diluted) | $1.65 | -3.5% |